Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.44B |
| 2 |
Microsoft
MSFT
|
+$556M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$433M |
| 4 |
Johnson & Johnson
JNJ
|
+$349M |
| 5 |
Amazon
AMZN
|
+$340M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$873M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$799M |
| 3 |
Colgate-Palmolive
CL
|
+$602M |
| 4 |
Palo Alto Networks
PANW
|
+$574M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$405M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.33% |
| 2 | Financials | 13.77% |
| 3 | Healthcare | 12.44% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Crocs
CROX
$6.47B
| $4.18M | ﹤0.01% |
60,855
+32,441
| +114% | +$2.25M |
|
1252
The Ensign Group
ENSG
$10.3B
| $4.18M | ﹤0.01% |
52,530
+13,731
| +35% | +$1.14M |
|
1253
CubeSmart
CUBE
$9.47B
| $4.17M | ﹤0.01% |
104,116
+20,049
| +24% | +$904K |
|
|
DVAX
1254
DELISTED
Dynavax Technologies
DVAX
| $4.15M | ﹤0.01% |
397,501
+359,235
| +939% | +$4.68M |
|
|
SAGE
1255
DELISTED
Sage Therapeutics
SAGE
| $4.13M | ﹤0.01% |
105,566
+99,159
| +1,548% | +$3.83M |
|
1256
Prothena Corp
PRTA
$436M
| $4.13M | ﹤0.01% |
68,062
+66,281
| +3,722% | +$2.1M |
|
1257
TD Synnex
SNX
$20.3B
| $4.1M | ﹤0.01% |
50,554
+44,189
| +694% | +$4.22M |
|
|
JAMF
1258
DELISTED
Jamf
JAMF
| $4.1M | ﹤0.01% |
185,134
+6,599
| +4% | +$163K |
|
1259
Medpace
MEDP
$16B
| $4.1M | ﹤0.01% |
26,092
+14,963
| +134% | +$2.39M |
|
|
LADR
1260
Ladder Capital
LADR
$1.23B
| $4.1M | ﹤0.01% |
457,429
+86,341
| +23% | +$953K |
|
1261
UFP Industries
UFPI
$5.18B
| $4.1M | ﹤0.01% |
56,742
+10,122
| +22% | +$805K |
|
|
JJT
1262
DELISTED
iPath Series B Bloomberg Tin Subindex Total ReturnSM ETN
JJT
| $4.07M | ﹤0.01% |
64,000
| – | – |
|
1263
Celldex Therapeutics
CLDX
$2.96B
| $4.06M | ﹤0.01% |
144,587
+47,500
| +49% | +$1.46M |
|
1264
WEX
WEX
$6.38B
| $4.06M | ﹤0.01% |
31,986
+16,484
| +106% | +$2.59M |
|
1265
Cable One
CABO
$254M
| $4.04M | ﹤0.01% |
4,741
+1,163
| +33% | +$1.44M |
|
1266
CALL
D.R. Horton
DHI
$41B
| $4.04M | ﹤0.01% |
60,000
| – | – |
|
|
AXON
1267
Axon Enterprise
AXON
$46.4B
| $4.04M | ﹤0.01% |
34,872
-9,319
| -21% | -$1.06M |
|
1268
Rhythm Pharmaceuticals
RYTM
$7.05B
| $4.03M | ﹤0.01% |
164,353
+155,063
| +1,669% | +$2.88M |
|
|
ZPTA
1269
DELISTED
Zapata Computing Holdings Inc. Common Stock
ZPTA
| $4.02M | ﹤0.01% |
400,000
| – | – |
|
|
AVID
1270
DELISTED
Avid Technology Inc
AVID
| $4.02M | ﹤0.01% |
172,961
+171,165
| +9,530% | +$4.47M |
|
1271
Ovintiv
OVV
$17.1B
| $4.02M | ﹤0.01% |
87,422
-67,036
| -43% | -$3.2M |
|
|
JWAC
1272
DELISTED
Jupiter Wellness Acquisition Corp. Class A Common Stock
JWAC
| $4.01M | ﹤0.01% |
400,302
+302
| +0.1% | +$3.02K |
|
1273
Fox Class B
FOX
$22.1B
| $4.01M | ﹤0.01% |
140,838
+58,431
| +71% | +$1.83M |
|
1274
Fate Therapeutics
FATE
$291M
| $4.01M | ﹤0.01% |
178,915
+158,098
| +759% | +$4.57M |
|
1275
MSC Industrial Direct
MSM
$6.98B
| $4.01M | ﹤0.01% |
55,040
+43,992
| +398% | +$3.47M |
|
Similar funds
Barclays's Q3 2022 Portfolio in Review
As of Q3 2022, Barclays held 5,400 positions worth $91.6B, down 44% from $163B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $66.4B in Q3 2022, closing 533 positions and reducing 1,954 holdings. Its most notable exit was Vonage Holdings Corporation, an estimated $99.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Barclays opened a new position in Pacer iPath Gold ETNs worth $27.1M.
- Barclays's largest Q3 2022 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $27.1M.
- Barclays added most to Apple in Q3 2022, an estimated $1.44B increase.
- Barclays's biggest Q3 2022 reduction was Invesco QQQ Trust, cutting an estimated $873M.
- Barclays fully exited Vonage Holdings Corporation in Q3 2022, selling an estimated $99.4M.
- Barclays's ten largest holdings make up 22% of its $91.6B portfolio in Q3 2022.
- Barclays opened 261 new positions and closed 533 in Q3 2022.
- Barclays's portfolio value fell 44% quarter-over-quarter to $91.6B.
Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.